Mersana Therapeutics, Inc.: accounts_payable
| Value | {"amount": 7319000, "concept": "us-gaap:AccountsPayableCurrent", "currency": "USD"} |
|---|---|
| Period | (as of 2023-12-31) |
| Status | current |
| Entity | Mersana Therapeutics, Inc. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T14:14:31.671154+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/4fe93801-ffb8-473a-ba03-030b5623d10c
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001628280-24-007407Retrieved: 2026-08-19T14:14:31.671154+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001442836/accounts-payable/2023-12-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/4fe93801-ffb8-473a-ba03-030b5623d10c
History
- no predecessors — first report